TrialLeukemia2009

Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial.

C B Reeder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.